Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis

NCT07220408 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: TL-925
DRUG: Placebo

Sponsor

Telios Pharma, Inc.